ENDOCRINE-CONTROL THERAPY IN PROSTATIC CANCER
β Scribed by J. D. Fergusson
- Book ID
- 115190304
- Publisher
- John Wiley and Sons
- Year
- 1958
- Tongue
- English
- Weight
- 870 KB
- Volume
- 30
- Category
- Article
- ISSN
- 1464-4096
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Twenty patients with advanced prostate cancer have been treated with an intermittent endocrine therapy schedule. Hormone therapy (diethylstilbestrol in 19 patients and flutamide in 1 patient) was administered until a clinical response was clearly demonstrated and then it was withheld until symptoms
Despite the initial androgen-dependent growth of most human prostate cancers, eventually all prostate cancers become androgen-independent at varying intervals after androgen ablation or anti-androgen therapy. In order to gain more insight into the role of the androgen receptor (AR) in this process,